Dr. Kennedy on Next Steps With SIRFLOX Trial in Liver-Metastatic CRC

In Partnership With:

Andrew Kennedy, MD, physician-in-chief and radiation oncologist at Sarah Cannon Research Institute, discusses the next steps following the SIRFLOX clinical trial for patients with liver-metastatic colorectal cancer (CRC).

Andrew Kennedy, MD, physician-in-chief and radiation oncologist at Sarah Cannon Research Institute, discusses the next steps following the SIRFLOX clinical trial for patients with liver-metastatic colorectal cancer (CRC).

Related Videos
Amandeep Godara, MBBS
Eunice Wang, MD
Yvonne Chao, MD, PhD
Sapna Patel, BA, MD
Brian Henick, MD
R. Lor Randall, MD, FACS
Edward B. Garon, MD, MS, professor of medicine, Department of Medicine, Division of Hematology/Oncology, David Geffen School of Medicine, the University of California, Los Angeles (UCLA), UCLA Health
Matthew Brunner, MD, assistant professor, hematologic specialist, medical oncology, and palliative care, Department of Medicine, University of Wisconsin Carbone Cancer Center
Experts on CRC
Related Content

Investigators Struggle to Understand Causes Behind Growth of Appendix Cancer

March 16th 2023

FDA Approval Insights: Zanubrutinib in CLL and SLL

February 16th 2023

Utilizing PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer in a Tailored Fashion

March 14th 2023

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

February 9th 2023

AB011 Plus CAPOX Demonstrates Preliminary Safety, Efficacy in Advanced Gastric/GEJ Cancer

March 13th 2023

State of Science Summit- GI Cancers: Chaired by Jimmy Hwang, MD

March 9th 2023

Investigators Struggle to Understand Causes Behind Growth of Appendix Cancer

March 16th 2023

FDA Approval Insights: Zanubrutinib in CLL and SLL

February 16th 2023

Utilizing PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer in a Tailored Fashion

March 14th 2023

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

February 9th 2023

AB011 Plus CAPOX Demonstrates Preliminary Safety, Efficacy in Advanced Gastric/GEJ Cancer

March 13th 2023

State of Science Summit- GI Cancers: Chaired by Jimmy Hwang, MD

March 9th 2023

Investigators Struggle to Understand Causes Behind Growth of Appendix Cancer

March 16th 2023

FDA Approval Insights: Zanubrutinib in CLL and SLL

February 16th 2023

Utilizing PARP Inhibitors in Metastatic Castration-Resistant Prostate Cancer in a Tailored Fashion

March 14th 2023

D'Amato Discusses Research and Resistance Mechanisms in Sarcoma and Gastrointestinal Stromal Tumor

February 9th 2023

AB011 Plus CAPOX Demonstrates Preliminary Safety, Efficacy in Advanced Gastric/GEJ Cancer

March 13th 2023

State of Science Summit- GI Cancers: Chaired by Jimmy Hwang, MD

March 9th 2023